spironolactone has been researched along with hydroxyproline in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chilakamarri, VK; Dhalla, AK; Ganjam, VK; Nasr, S; Ramires, FJ; Slight, SH; Sun, Y; Weber, KT | 1 |
| Bakas, P; Creatsas, G; Gregoriou, O; Konidaris, S; Mathiopoulos, D; Papadias, K | 1 |
| Huang, CX; Jiang, H; Jiang, XJ; Liang, YH; Wang, JM; Zhou, Y | 1 |
| Fujisawa, G; Ishibashi, S; Kusano, E; Muto, S; Okada, K | 1 |
| Camp, JR; Cavallari, LH; Fashingbauer, LA; Geenen, DL; King, ST | 1 |
| Koda, M; Matono, T; Murawaki, Y; Sugihara, T; Tokunaga, S; Ueki, M | 1 |
| Azevedo, PS; Chiuso-Minicucci, F; dos Santos, PP; Gonçalves, AF; Minicucci, MF; Okoshi, K; Paiva, SA; Pereira, EJ; Polegato, BF; Rafacho, BP; Silva, RA; Zornoff, LA | 1 |
1 trial(s) available for spironolactone and hydroxyproline
| Article | Year |
|---|---|
The effect of combined oral contraception with or without spironolactone on bone mineral density of hyperandrogenic women.
Topics: Adult; Alkaline Phosphatase; Bone Density; Calcium; Contraceptives, Oral, Combined; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydroxyproline; Hyperandrogenism; Luteinizing Hormone; Osteocalcin; Phosphates; Spironolactone | 2000 |
6 other study(ies) available for spironolactone and hydroxyproline
| Article | Year |
|---|---|
Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adrenalectomy; Aldosterone; Animals; Diet; Gene Expression; Granulation Tissue; Hydroxyproline; Hydroxysteroid Dehydrogenases; Male; Mineralocorticoids; Models, Biological; Rats; Rats, Sprague-Dawley; Sodium Chloride; Spironolactone; Wound Healing | 1998 |
Additive effects of combined valsartan and spironolactone on cardiac aldosterone escape in spontaneously hypertensive rats.
Topics: Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Central Venous Pressure; Chromatography, High Pressure Liquid; Collagen; Heart; Hydroxyproline; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Spironolactone; Tetrazoles; Valine; Valsartan | 2004 |
Mineralocorticoid receptor antagonist spironolactone prevents pig serum-induced hepatic fibrosis in rats.
Topics: Actins; Aldosterone; Animals; Cytochrome P-450 CYP11B2; Hydroxyproline; Kupffer Cells; Liver; Liver Cirrhosis, Experimental; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Sodium-Hydrogen Exchangers; Spironolactone; Swine | 2006 |
Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression.
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Collagen Type I; Fibrosis; Gene Expression Regulation; Hydroxyproline; Hypertension; Kidney; Male; Organ Size; Rats; Rats, Inbred Strains; Receptors, Mineralocorticoid; Spironolactone; Systole | 2008 |
The effects of the selective mineralocorticoid receptor antagonist eplerenone on hepatic fibrosis induced by bile duct ligation in rat.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Animals; Bile Ducts; Deoxyguanosine; Eplerenone; Gene Expression Regulation; Hydroxyproline; Immunohistochemistry; Ligation; Lipid Peroxidation; Liver Cirrhosis; Male; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Spironolactone | 2010 |
Mechanisms involved in the beneficial effects of spironolactone after myocardial infarction.
Topics: Analysis of Variance; Animals; Blotting, Western; Body Weights and Measures; Collagen; Echocardiography; Hydroxyproline; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mineralocorticoid Receptor Antagonists; Muscle Cells; Myocardial Infarction; Rats; Rats, Wistar; Spironolactone; Tissue Inhibitor of Metalloproteinase-1; Ventricular Function, Left; Ventricular Remodeling | 2013 |